Psoriatic Arthritis News

While there is a cross-section of drugs that are FDA-approved for the treatment of axial spondyloarthritis, clinicians and researchers continue to struggle with axial psoriatic arthritis, according to a presenter at ACR Convergence 2021.

Among fully vaccinated individuals with rheumatic diseases, breakthrough COVID-19 infections occurred most commonly in patients treated with B cell depleting agents or mycophenolate, according to data presented at ACR Convergence 2021.

Therapeutic drug monitoring, in which serum levels are regularly checked to adjust dose and intervals, is more effective at controlling disease than standard therapy with infliximab, according to data presented at ACR Convergence 2021.

The use of vitamin D3 or omega-3 fatty acid supplements over a 5-year period may reduce the incidence of autoimmune disease in older adults by 25% to 30%, according to data presented at ACR Convergence 2021.

Hospitalizations for sepsis, skin and soft tissue infections and UTI among patients with psoriatic arthritis “significantly” decreased over a 5-year period despite a rising uptake in biologics, according to data presented at ACR Convergence 2021.

Patients with chronic inflammatory disease on immunosuppressants, especially B-cell depleting agents, mycophenolate and glucocorticoids, exhibited poor antibody responses to the mRNA vaccine for COVID-19, according to a presenter here.

Risankizumab provides statistically greater improvements in signs and symptoms relative to placebo, and is well tolerated among patients with psoriatic arthritis, according to data presented at ACR Convergence 2021.

The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis, multiple sclerosis and certain other autoimmune diseases, according to a company press release.

Among patients treated with TNF inhibitors, the risk for serious infection was “significantly lower” in those with psoriatic arthritis compared with rheumatoid arthritis, according to data published in the Annals of the Rheumatic Diseases.

Physical activity can lead to improved quality of life and self-reported function in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis, according to data published in Arthritis Care & Research.